Pro Share Advisors LLC Pacira Bio Sciences, Inc. Transaction History

Pro Share Advisors LLC

  • $48.7 Billion
  • Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 12,007 shares of PCRX stock, worth $272,919. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,007
Previous 12,887 6.83%
Holding current value
$272,919
Previous $320,000 10.63%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$22.91 - $27.14 $20,160 - $23,883
-880 Reduced 6.83%
12,007 $286,000
Q1 2025

May 08, 2025
SELL
$18.33 - $27.25 $57,116 - $84,911
-3,116 Reduced 19.47%
12,887 $320,000
Q4 2024

Feb 13, 2025
BUY
$15.3 - $20.33 $56,763 - $75,424
3,710 Added 30.18%
16,003 $301,000
Q3 2024

Nov 13, 2024
BUY
$11.7 - $28.46 $27,951 - $67,990
2,389 Added 24.12%
12,293 $185,000
Q2 2024

Aug 13, 2024
SELL
$25.5 - $31.51 $65,203 - $80,571
-2,557 Reduced 20.52%
9,904 $283,000
Q1 2024

May 08, 2024
BUY
$27.7 - $35.48 $25,594 - $32,783
924 Added 8.01%
12,461 $364,000
Q4 2023

Feb 14, 2024
BUY
$26.32 - $34.31 $40,796 - $53,180
1,550 Added 15.52%
11,537 $389,000
Q3 2023

Nov 13, 2023
SELL
$30.68 - $40.09 $3,528 - $4,610
-115 Reduced 1.14%
9,987 $306,000
Q2 2023

Aug 10, 2023
BUY
$36.12 - $47.5 $13,581 - $17,860
376 Added 3.87%
10,102 $404,000
Q1 2023

May 11, 2023
SELL
$35.53 - $43.38 $42,209 - $51,535
-1,188 Reduced 10.89%
9,726 $396,000
Q4 2022

Feb 02, 2023
BUY
$38.19 - $57.45 $32,843 - $49,407
860 Added 8.55%
10,914 $421,000
Q3 2022

Nov 04, 2022
BUY
$51.24 - $58.89 $8,403 - $9,657
164 Added 1.66%
10,054 $534,000
Q2 2022

Aug 01, 2022
SELL
$51.49 - $81.64 $236,081 - $374,319
-4,585 Reduced 31.68%
9,890 $576,000
Q1 2022

May 10, 2022
SELL
$60.03 - $76.49 $170,545 - $217,308
-2,841 Reduced 16.41%
14,475 $1.1 Million
Q4 2021

Feb 08, 2022
BUY
$47.97 - $62.21 $51,759 - $67,124
1,079 Added 6.65%
17,316 $1.04 Million
Q3 2021

Nov 12, 2021
SELL
$54.64 - $61.3 $229,160 - $257,092
-4,194 Reduced 20.53%
16,237 $909,000
Q2 2021

Aug 13, 2021
BUY
$59.18 - $69.99 $101,197 - $119,682
1,710 Added 9.13%
20,431 $1.24 Million
Q1 2021

May 14, 2021
BUY
$59.31 - $78.82 $102,843 - $136,673
1,734 Added 10.21%
18,721 $1.31 Million
Q4 2020

Feb 09, 2021
BUY
$50.47 - $66.26 $211,216 - $277,298
4,185 Added 32.69%
16,987 $1.02 Million
Q3 2020

Nov 13, 2020
SELL
$51.97 - $63.0 $13,200 - $16,002
-254 Reduced 1.95%
12,802 $770,000
Q2 2020

Aug 03, 2020
BUY
$30.8 - $52.47 $130,499 - $222,315
4,237 Added 48.04%
13,056 $685,000
Q1 2020

May 15, 2020
SELL
$28.4 - $50.7 $196,187 - $350,235
-6,908 Reduced 43.92%
8,819 $296,000
Q4 2019

Feb 12, 2020
SELL
$36.31 - $46.83 $44,044 - $56,804
-1,213 Reduced 7.16%
15,727 $712,000
Q3 2019

Nov 12, 2019
BUY
$35.66 - $44.99 $23,678 - $29,873
664 Added 4.08%
16,940 $645,000
Q2 2019

Aug 13, 2019
SELL
$36.57 - $47.97 $75,626 - $99,201
-2,068 Reduced 11.27%
16,276 $708,000
Q1 2019

May 15, 2019
BUY
$36.47 - $42.17 $8,278 - $9,572
227 Added 1.25%
18,344 $698,000
Q4 2018

Feb 14, 2019
SELL
$41.31 - $52.16 $143,221 - $180,838
-3,467 Reduced 16.06%
18,117 $779,000
Q3 2018

Nov 14, 2018
SELL
$32.85 - $52.0 $57,816 - $91,520
-1,760 Reduced 7.54%
21,584 $1.06 Million
Q2 2018

Aug 13, 2018
SELL
$27.5 - $39.8 $44,110 - $63,839
-1,604 Reduced 6.43%
23,344 $748,000
Q1 2018

May 14, 2018
SELL
$29.98 - $46.35 $115,033 - $177,844
-3,837 Reduced 13.33%
24,948 $777,000
Q4 2017

Feb 14, 2018
BUY
$31.85 - $46.95 $76,376 - $112,586
2,398 Added 9.09%
28,785 $1.31 Million
Q3 2017

Nov 13, 2017
BUY
$35.7 - $39.5 $53,371 - $59,052
1,495 Added 6.01%
26,387 $991,000
Q2 2017

Aug 11, 2017
BUY
N/A
24,892
24,892 $1.19 Million

Others Institutions Holding PCRX

# of Institutions
259
Shares Held
51.2M
Call Options Held
289K
Put Options Held
130K
View Full List

About Pacira BioSciences, Inc.

PCRX Quotes by TradingView
  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.04B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email